R&D, Pharmacovigilance & Regulatory Affairs

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
Title Location Sort descending Date Req ID
Reset
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT Jul 11, 2026 6111
Europe, IT Jul 11, 2026 6111
Clinical Research Physician, Global Rare Diseases
Clinical Research Physician, Global Rare Diseases Europe - Remote, IT Jun 23, 2026 7356
Europe - Remote, IT Jun 23, 2026 7356
Manager, EU & International Regulatory Affairs, Global Rare Diseases
Manager, EU & International Regulatory Affairs, Global Rare Diseases Dublin, IE Jul 11, 2026 7302
Dublin, IE Jul 11, 2026 7302
Manager, Americas Regulatory Affairs Labeling & Promotion, Global Rare Diseases
Manager, Americas Regulatory Affairs Labeling & Promotion, Global Rare Diseases Cary, NC, US Jul 17, 2026 7526
Cary, NC, US Jul 17, 2026 7526